The step is aimed at strengthening regulatory oversight and ensuring uniform compliance in the conduct of pharmacy examinations across the country.
As per the official communication issued on January 19, 2026, all Examining Authorities are required to complete their registration on the designated PCI portal under the “Examining Authority Registration” section. The portal will go live from January 21, 2026, and the deadline for completing the registration and application process has been set as February 21, 2026.
PCI has clarified that the approval granted to Examining Authorities will be valid for a period of five years. After the expiry of this tenure, renewal of approval will be mandatory. Further, the authorities have been instructed to regularly update details related to examination schedules and academic calendars, along with the list of affiliated institutions for which consent has been granted. These details are required to be updated annually or whenever changes take place during the approval period.
The council has also notified the applicable fee structure for the approval process. Examining Authorities will have to pay a registration fee of ₹10,000 plus GST. In addition, an application regulatory fee of ₹1 lakh plus GST will be applicable for a tenure of five years.
To facilitate the approval process, PCI has laid down a comprehensive list of statutory documents that must be uploaded on the portal. These include Gazette notifications declaring the status of universities, relevant provisions of Acts empowering institutions to conduct pharmacy courses and examinations, resolutions of governing bodies where applicable, and certificates from Registrars confirming the willingness to conduct pharmacy examinations. Distinct documentation requirements have been prescribed for Central and State Government Universities, private universities, deemed-to-be universities, and State Pharmacy Councils.
For institutions encountering technical issues during the registration or application process, PCI has provided an online grievance redressal mechanism through the portal. Users have been advised to raise issues under the appropriate user category to ensure timely resolution.
The directive is expected to enhance transparency, accountability, and regulatory consistency in the examination and certification process for pharmacy education in India, while ensuring strict adherence to the statutory provisions of the Pharmacy Act, 1948.
To view the official notification, click on the link below:
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.